Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Xiucai Xu"'
Autor:
Lin Wang, He Chen, Daohua Liu, Xingxing Huo, Jiangmei Gao, Xiaorong Song, Xiucai Xu, Kaiquan Huang, Wenqi Liu, Yong Wang, Fangli Lu, Zhao-Rong Lun, Qingli Luo, Xuelong Wang, Jilong Shen
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53483 (2013)
BACKGROUND: Recent population structure studies of T. gondii revealed that a few major clonal lineages predominated in different geographical regions. T. gondii in South America is genetically and biologically divergent, whereas this parasite is rema
Externí odkaz:
https://doaj.org/article/a6291604f91f45d58da624e08a7f9121
Autor:
Lin Wang, He Chen, Daohua Liu, Xingxing Huo, Jiangmei Gao, Xiaorong Song, Xiucai Xu, Kaiquan Huang, Wenqi Liu, Yong Wang, Fangli Lu, Zhao-Rong Lun, Qingli Luo, Xuelong Wang, Jilong Shen
Publikováno v:
PLoS ONE, Vol 8, Iss 5 (2013)
Externí odkaz:
https://doaj.org/article/f24f3693c10b41e88f3876b27a40f3cb
Autor:
Jian Du, Ran An, Lijian Chen, Yuxian Shen, Ying Chen, Li Cheng, Zhongru Jiang, Aimei Zhang, Li Yu, Deyong Chu, Yujun Shen, Qingli Luo, He Chen, Lijuan Wan, Min Li, Xiucai Xu, Jilong Shen
Publikováno v:
J Biol Chem
The obligate intracellular parasite Toxoplasma gondii secretes effector molecules into the host cell to modulate host immunity. Previous studies have shown that T. gondii could interfere with host NF-κB signaling to promote their survival, but the e
Publikováno v:
ProteomicsREFERENCES. 22(1-2)
Although tyrosine kinase inhibitors (TKIs), including imatinib, have greatly improved clinical treatment of patients with chronic myeloid leukemia (CML), drug resistance remains a major obstacle. Studies on the mechanisms underlying imatinib resistan
Autor:
Kaidi Song, Zimin Sun, Wen Yao, Huilan Liu, Baolin Tang, Xiang Wan, Xiucai Xu, Lei Zhang, Juan Tong, Xiaoyu Zhu, Guangyu Sun, Xuhan Zhang, Changcheng Zheng
Publikováno v:
Annals of Hematology
This is a retrospective study comparing the effectiveness of umbilical cord blood transplantation (UCBT) and chemotherapy for patients in the first complete remission period for acute myeloid leukemia with KMT2A-MLLT3 rearrangements. A total of 22 pa
Publikováno v:
Leukemia & Lymphoma. 60:1709-1720
MicroRNAs (miRNAs) are involved in various processes from the development to drug resistance of tumors, including chronic myeloid leukemia (CML). In this study, we examined the STAT5-related miRNA-expression profile in CML cell lines (K562 and imatin
Publikováno v:
Experimental and Therapeutic Medicine
Imatinib (IM) is successfully used in the majority of patients with chronic myeloid leukemia (CML), but some patients develop resistance to drug treatment. Insufficient apoptosis results in uncontrolled cell proliferation, which is closely associated
Autor:
Wei-Wei Wang, Yihong Cai, Aimei Zhang, Yihua Zhang, Xiucai Xu, Qian Zhang, Lu Wang, Lanting Kong, Ran An, He Chen, Jilong Shen, Qingli Luo, Min Li, Huiqin Wen, Liuyuan He
Publikováno v:
Journal of Parasitology. 101:418-423
Toxoplasma gondii induces polarization of mouse macrophages, including both classically activated macrophages (M1) and alternatively activated macrophages (M2) in a genotype-related manner. Here we present a novel result that the Wh6 strain with type
Publikováno v:
Experimental Parasitology. 154:51-61
Congenital toxoplasmosis may result in abortion, severe mental retardation and neurologic damage in the offspring. Placental damage is considered as the key event in this disease. Here we show that maternal infection with Toxoplasma gondii Wh3 isolat
Publikováno v:
Experimental and Therapeutic Medicine
High expression of the Wilms' tumor gene (WT1) in acute myeloid leukemia (AML) has been considered as a sensitive marker of minimal residual disease (MRD). The present study investigated the significance of quantitative analysis of WT1 mRNA, combined